AeroLeads people directory · profile

Michael Hite Email & Phone Number

CEO at Ayuda Medical at Ayuda Medical
Location: Seattle, Washington, United States 4 work roles 2 schools
LinkedIn matched
✓ Verified July 2026 3 data sources Profile completeness 86%

Contact Signals

LinkedIn Profile matched
3 free lookups remaining · No credit card
Current company
Role
CEO at Ayuda Medical
Location
Seattle, Washington, United States

Who is Michael Hite? Overview

A concise factual answer block for searchers comparing this professional profile.

Quick answer

Michael Hite is listed as CEO at Ayuda Medical at Ayuda Medical, based in Seattle, Washington, United States. AeroLeads shows a matched LinkedIn profile for Michael Hite.

Michael Hite previously worked as Chief Executive Officer at Ayuda Medical and CEO at Impel Neuropharma. Michael Hite holds Mba, Entrepreneurship, Strategy from Uw Foster School Of Business.

Company email context

Email format at Ayuda Medical

This section adds company-level context without repeating Michael Hite's masked contact details.

Ayuda Medical

Review company-level records connected to Michael Hite before choosing the right outreach path.

Profile bio

About Michael Hite

Michael Hite is a CEO at Ayuda Medical at Ayuda Medical.

Current workplace

Michael Hite's current company

Company context helps verify the profile and gives searchers a useful next step.

Ayuda Medical
Ayuda Medical
CEO at Ayuda Medical
9030 35th Ave SW,
Website
AeroLeads page
4 roles · 28 years

Michael Hite work experience

A career timeline built from the work history available for this profile.

Chief Executive Officer

Current

Ayuda Medical is developing a medical wearable to prevent fatal drug overdose. The ARMband is a small disccret band that will detect signs of potentially life-threatening overdose. The ARMband is designed with on-board logic as a stand alone device -- no internet connection is required -- enabling patients to be protected at home, at work, and when out with friends. In the event of an overdose, the ARMband alarms, gives instructions to bystanders, and sends text and phone alerts to designated contacts. The ARMband isn't a remote patient-monitor, it's only activated in the event of an overdose -- it does not capturing unnecessary data or track location -- but it's always there if patients need help, even when they're alone. We believe that everyone should have access to overdose prevention resources. We are committed to ensuring the ARMband is brought to market as an affordable medical device, accessible and available to all patients.Anyone who is exposed to opiates can be at risk of an overdose, especially in combination with other sedating medications. The risk of overdose has increased significantly in recent years due to the potent opioid fentanyl, and emergence of fentanyl-sedative combinations, such as fentanyl-xylazine. Sedatives such as xylazine complicate overdose response because they extend the effects of opioids, and do not respond to naloxone (Narcan) in the same way as opioids alone. Many times the effects of fentanyl-xylazine overdoses are nearly instantaneous, requiring immediate medical response, but in other cases, occur hours later. The need for a wearable, inexpensive overdose alarm has never been greater.Ayuda is developing the ARMband in conjunction with an active NIH/NIDA Phase 2 SBIR grant. We greatly appreciate the work of everyone working at to improve the lives of people with Substance Use Disorders.

Nov 2017 - Present

Ceo

Impel Neuropharma

Impel NeuroPharma is focused on developing transformative therapies for people living with central nervous system (CNS) disorders through the pioneering of an optimized approach to drug delivery: the Company’s proprietary upper nasal delivery technology, known as the Precision Olfactory Delivery (POD®) device, which we developed from the concept into the clinic during my time as CEO. The upper nasal space is surrounded by a rich vasculature that has the potential for injection-like absorption, resulting in more rapid and consistent bioavailability and clinical response. While an ideal target for drug delivery, to date no technology has been able to consistently deliver drugs predictably and consistently to the upper nasal area. We founded Impel with the goal of being the first company to successfully enable delivery to this region because of the value we believed it could bring to patients. I'm proud of the incredible team we built and the tremendous potential we demonstrated that is possible using the Impel platform. Impel has recently had a successful IPO (NASDAQ: IMPL) and is now awaiting FDA decision on their first product, TRUDHESA (intranasal dihydroergotamine mesylate). I'm excited for their success and for the future opportunities for "nose-to-brain" therapeutics that the technology will enable.

Jan 2008 - Nov 2016

Project Manager

Scolr Pharma, Inc.

Pharmaceutical Formulation, Drug Target Selection, Business Development, Product Development, Intellectual Property Creation and Management

Jun 2000 - Jun 2008

Research Technician

Uw Genome Center
1999 - 2000 ~1 yr
2 education records

Michael Hite education

Mba, Entrepreneurship, Strategy

Uw Foster School Of Business

Bachelor Of Arts (Ba), Russian Studies

Amherst College
FAQ

Frequently asked questions about Michael Hite

Quick answers generated from the profile data available on this page.

What company does Michael Hite work for?

Michael Hite works for Ayuda Medical.

What is Michael Hite's role at Ayuda Medical?

Michael Hite is listed as CEO at Ayuda Medical at Ayuda Medical.

Where is Michael Hite based?

Michael Hite is based in Seattle, Washington, United States while working with Ayuda Medical.

What companies has Michael Hite worked for?

Michael Hite has worked for Ayuda Medical, Impel Neuropharma, Scolr Pharma, Inc., and Uw Genome Center.

How can I contact Michael Hite?

You can use AeroLeads to view verified contact signals for Michael Hite at Ayuda Medical, including work email, phone, and LinkedIn data when available.

What schools did Michael Hite attend?

Michael Hite holds Mba, Entrepreneurship, Strategy from Uw Foster School Of Business.

Find 750M verified contacts

Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.